FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3015941411> ?p ?o ?g. }

• W3015941411 endingPage "685" @default.
• W3015941411 startingPage "676" @default.
• W3015941411 abstract "Objective This study aimed to assess prospectively the role of anti-ß2-glycoprotein I domain I antibody (aß2GPI-DI) and the Global Antiphospholipid Syndrome Score (GAPSS) in identifying antiphospholipid syndrome (APS) patients at higher risk of a new event. Methods Thrombotic APS patients were followed from May 2013 to July 2017. At baseline, we measured lupus anticoagulant, IgG/IgM anticardiolipin, anti-ß2-glycoprotein I, antiphosphatidylserine-prothrombin (aPS/PT) and IgG aß2GPI-DI, and calculated GAPSS for each patient. Results A total of 44 patients (age 43 ± 10 years, 89% female, 73% primary APS) were followed for 39 months (range 9–46 months). Four new thromboses occurred, two of them after vitamin K antagonist interruption. Recurrent patients presented higher GAPSS (median 20) and were triple and aß2GPI-DI positive; non-recurrent patients had lower GAPSS (median 10.5, range 0–20) and lower ratio of triple (33%) and aß2GPI-DI positivities (38%). aß2GPI-DI was associated with higher GAPSS (median 19 vs. 7, p < 0.001; Pearson correlation 0.82, p < 0.001) and had a greater proportion of triple (83% vs. 4%, p < 0.001) and aPS/PT positivity (94% vs. 50%, p = 0.002). Conclusion Our data show a significant correlation between a validated risk score such as GAPSS and the novel antiphospholipid antibody aß2GPI-DI. Future studies are needed. However, one could speculate a role of aß2GPI-DI as a risk-stratifying tool for thrombotic events in APS." @default.
• W3015941411 created "2020-04-17" @default.
• W3015941411 creator A5017039749 @default.
• W3015941411 creator A5035234501 @default.
• W3015941411 creator A5052730073 @default.
• W3015941411 creator A5054660181 @default.
• W3015941411 creator A5082357875 @default.
• W3015941411 date "2020-04-11" @default.
• W3015941411 modified "2023-10-18" @default.
• W3015941411 title "Global antiphospholipid syndrome score and anti-ß2-glycoprotein I domain I for thrombotic risk stratification in antiphospholipid syndrome: A four-year prospective study" @default.
• W3015941411 cites W1488742384 @default.
• W3015941411 cites W1574152642 @default.
• W3015941411 cites W1578529971 @default.
• W3015941411 cites W1820213619 @default.
• W3015941411 cites W1872365828 @default.
• W3015941411 cites W1992631495 @default.
• W3015941411 cites W2001955212 @default.
• W3015941411 cites W2005750417 @default.
• W3015941411 cites W2006745686 @default.
• W3015941411 cites W2012278948 @default.
• W3015941411 cites W2041919675 @default.
• W3015941411 cites W2042958596 @default.
• W3015941411 cites W2054330426 @default.
• W3015941411 cites W2054644746 @default.
• W3015941411 cites W2055791340 @default.
• W3015941411 cites W2069797332 @default.
• W3015941411 cites W2070760253 @default.
• W3015941411 cites W2090109431 @default.
• W3015941411 cites W2094434475 @default.
• W3015941411 cites W2101326680 @default.
• W3015941411 cites W2112823451 @default.
• W3015941411 cites W2113738930 @default.
• W3015941411 cites W2120492526 @default.
• W3015941411 cites W2127565509 @default.
• W3015941411 cites W2143086319 @default.
• W3015941411 cites W2143891179 @default.
• W3015941411 cites W2148092884 @default.
• W3015941411 cites W2149675904 @default.
• W3015941411 cites W2230897915 @default.
• W3015941411 cites W2261553658 @default.
• W3015941411 cites W2318842997 @default.
• W3015941411 cites W2327141264 @default.
• W3015941411 cites W2328956786 @default.
• W3015941411 cites W2414585286 @default.
• W3015941411 cites W2440701858 @default.
• W3015941411 cites W2589187715 @default.
• W3015941411 cites W2604334482 @default.
• W3015941411 cites W2621312629 @default.
• W3015941411 cites W2726871844 @default.
• W3015941411 cites W2742548756 @default.
• W3015941411 cites W2784285632 @default.
• W3015941411 cites W2792087609 @default.
• W3015941411 cites W2811000002 @default.
• W3015941411 cites W2894220218 @default.
• W3015941411 cites W2904420984 @default.
• W3015941411 cites W4296981399 @default.
• W3015941411 doi "https://doi.org/10.1177/0961203320916527" @default.
• W3015941411 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32279584" @default.
• W3015941411 hasPublicationYear "2020" @default.
• W3015941411 type Work @default.
• W3015941411 sameAs 3015941411 @default.
• W3015941411 citedByCount "11" @default.
• W3015941411 countsByYear W30159414112020 @default.
• W3015941411 countsByYear W30159414112021 @default.
• W3015941411 countsByYear W30159414112022 @default.
• W3015941411 countsByYear W30159414112023 @default.
• W3015941411 crossrefType "journal-article" @default.
• W3015941411 hasAuthorship W3015941411A5017039749 @default.
• W3015941411 hasAuthorship W3015941411A5035234501 @default.
• W3015941411 hasAuthorship W3015941411A5052730073 @default.
• W3015941411 hasAuthorship W3015941411A5054660181 @default.
• W3015941411 hasAuthorship W3015941411A5082357875 @default.
• W3015941411 hasConcept C126322002 @default.
• W3015941411 hasConcept C159654299 @default.
• W3015941411 hasConcept C188816634 @default.
• W3015941411 hasConcept C203014093 @default.
• W3015941411 hasConcept C2776301958 @default.
• W3015941411 hasConcept C2776704044 @default.
• W3015941411 hasConcept C2776874634 @default.
• W3015941411 hasConcept C2779161974 @default.
• W3015941411 hasConcept C2780022809 @default.
• W3015941411 hasConcept C2780868729 @default.
• W3015941411 hasConcept C71924100 @default.
• W3015941411 hasConcept C90924648 @default.
• W3015941411 hasConceptScore W3015941411C126322002 @default.
• W3015941411 hasConceptScore W3015941411C159654299 @default.
• W3015941411 hasConceptScore W3015941411C188816634 @default.
• W3015941411 hasConceptScore W3015941411C203014093 @default.
• W3015941411 hasConceptScore W3015941411C2776301958 @default.
• W3015941411 hasConceptScore W3015941411C2776704044 @default.
• W3015941411 hasConceptScore W3015941411C2776874634 @default.
• W3015941411 hasConceptScore W3015941411C2779161974 @default.
• W3015941411 hasConceptScore W3015941411C2780022809 @default.
• W3015941411 hasConceptScore W3015941411C2780868729 @default.
• W3015941411 hasConceptScore W3015941411C71924100 @default.
• W3015941411 hasConceptScore W3015941411C90924648 @default.
• W3015941411 hasIssue "7" @default.
• W3015941411 hasLocation W30159414111 @default.

• next